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Clinical Reports 
The Exclusion of Restrictive Lung Disease by Spirometric 
Criteria in Patients with a Reduced Forced Vital Capacity 
Michael S. Eichenhorn, MD,* John Popovich, Jr, MD,* 
Richard K. Beauchamp, R-CPT, John Armstrong, MD, and Joseph C. Ward, MD* 
Reductions in forced vital capacity (EVC) as determined 
by spirometry may result from restrictive or obstructive 
disease, either alone or in combination. Restrictive dis-
ease is impUed when measures of forced expiratory flow 
are relatively maintained, and obstructive disease is 
present when flow measurements are disproportion-
ately reduced. In the presence of air flow obstruction, 
the possibiUty of concomitant restrictive disease contrib-
uting to the reduction in FVC is difficult to assess from 
spirometry alone. Static lung volumes are usually neces-
sary to establish this diagnosis. 
We evaluated the FEV-,/EVC%o obtained at spirometry 
compared to its predicted normal value. We found it to 
be useful in eliminating the need for additional testing in 
many cases in which the question of mixed obstructive 
and restrictive disease had been raised. Specifically, in 
patients with obstructive disease and a reduced FVC, 
an FEV-i/FVC% of less than 81%, of the age-, height-, and 
sex-matched predicted value largely excluded the pos-
sibility that concomitant restrictive disease was also pres-
ent (p<.05). Higher values had no predictive value. 
T h e patient's forced vital capacity (FVC) as determined 
by spirometry may be reduced as a result of obstructive 
or restrictive lung disease or combinations of these two 
condit ions. Poor terminal effort by the patient may also 
reduce the FVC, but this can usually be recognized by 
visual inspection of the spirometric tracing. Obstructive 
disease is considered to be present when the reduction 
in forced expiratory volume in one second (FEV) is 
greater than the reduction in FVC, i.e., the FEVi/FVC% is 
decreased. Obstructive disease is also present when the 
forced mid-expiratory f low (FEFjs./s) is reduced, even if 
the FEVi/FVC% is maintained. It is, however, not likely 
that air f low obstruction confined to the peripheral air-
ways as manifested by reductions in terminal f low could 
result in reductions in forced vital capacity (1). Restric-
tive disease may be implied f rom the spirogram when 
the FEVi/FVC% and FEF25.75 are maintained despite the 
reduction in FVC, although total lung capacity (TLC) 
must be reduced to less than 80% of its predicted value 
to establish this diagnosis definitely (2). 
When the FVC and FEV/FVC% are both markedly reduced, 
it is dif f icult to determine f rom the spirogram alone 
whether some element of restrictive disease is also pres-
ent. While visual inspection of simultaneous flow volume 
curves may provide some information, this method is 
not exact and requires extra technical apparatus. If a 
method could be devised that would permit the cl ini-
cian to accurately diagnose restrictive lung disease f rom 
the spirogram in these situations, it would help eliminate 
concern about the existence of concomitant unsus-
pected disease. It would also save the pulmonary labora-
tory f rom performing unnecessary static lung volume 
determinations. We have found the FEV/FVC% as com-
pared to its predicted value to be useful in this regard. 
Methods 
We reviewed studies of all patients referred to the Pul-
monary Function Laboratory for testing in two consecu-
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tive years. From 4,240 studies, 435 patients were identi-
fied with airflow obstruction and a reduced FVC (less 
than 80% predicted), for whom static lung volumes by 
plethysmography were also performed at the same sit-
t ing. Patients with reductions in the FEV/FVC% below 
that predicted for their height and age (by Morris's 
standards) (3) were considered to have air f low obstruc-
t ion. Patients with a TLC less than 80% of predicted 
(Goldman's standards) (4) were classified as restricted. In 
addit ion to routine spirometric analysis, we also calcu-
lated the ratio of the FEV, to the FVC actually obtained to 
that predicted. We then performed discriminant analysis 
of the above data. 
Results 
Patients ranged in age f rom 11-89 years, wi th a mean age 
of 55.3 years. There were 264 men and 171 women. Of 
435 patients, 344 had a normal or elevated total lung 
capacity, while 91 were restricted as defined above (Fig. 
1). We then applied parametric discriminant analysis to 
this population using the methodology of Mardi a (5) and 
Morr ison (6). In these patients with a reduced FVC, Xi 
was assigned to the mean FEV/FVCX of predicted for 
those patients with a TLC <80% of predicted, and x^ 
represented the FEVi/FVC% of predicted for those with 
a TLC >80% of predicted. Statistical analysis could then 
be determined; the cut-off point was one half (x, + x,). 
Fig. 1 
FEViFVC% (actual/predicted) vs total lung capacity (TLC). 
and an associated variance was equal to one fourth (var 
Xi + Xj). This revealed an estimated cut-off point of 0.81 at 
a 95% confidence level and a standard error of 0.01. 
Hence, when the FEVi/FVC% was less than 8 1 % of pre-
dicted, only 7% (17/228) of our patients had a reduced 
TLC. When the FEV/FVC% was greater than 81% of 
predicted, no clearcut discrimination could be made 
between those with or wi thout concomitant restrictive 
disease. 
We then studied the 17 cases which had low TLC values 
despite an FEVi/FVC% less than 81% of predicted. Unfor-
tunately, the records of three patients could not be 
located. Two other patients had diagnoses of "o ld 
tuberculosis," but their records did not contain enough 
information to deduce the extent of such disease. 
A definit ive cause for restrictive disease could be found 
in each of the remaining 12 cases. Four patients had 
roentgenographic evidence of significant prior granu-
lomatous disease, with a thoracoplasty in one case, a 
thoracoplasty and phrenic nerve section in one case, 
extensive pleural and parenchymal scarring in one case, 
and prior left upper lobectomy and complicating asper-
gilloma in one case. Three patients had carcinoma; one 
had a six cm right upper lobe mass together with a large 
right pleural effusion and interstitial infiltrates compati-
ble with lymphangitic spread, while two others had 
undergone earlier lobectomies for cancer. One addi-
tional patient had undergone earlier resection for bul-
lous emphysema, with prominent areas of persistent 
bullous change still evident. 
Four remaining patients had widespread parenchymal 
disease by clinical and roentgenographic analysis suffi-
cient to account for the observed reductions in TLC. 
There was one case each of Stage III sarcoidosis, con-
glomerate silicosis, Wegener's granulomatosis wi th 
extensive ret iculonodular infi ltrates, and sickle cell 
anemia with repeated pneumonias and pulmonary infarcts 
resulting in extensive fibrotic changes bilaterally. 
Discussion 
Spirometry remains a useful screening test for pulmo-
nary disease. Reductions in forced expiratory f low rates 
establish the presence of air f low obstruct ion, while 
maintenance of f low rates together with reductions in 
FVC imply a restrictive process. This latter diagnosis can 
be established only when TLC as judged by static lung 
volume measurements is also reduced. As air f low 
obstruction worsens, the FVC may also fall as a result of 
air trapping. In the presence of severe obstructive dis-
ease and a reduced FVC, it is often diff icult to determine 
whether some element of restrictive disease is also pres-
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ent. We have found the FEVi/FVC% to be a useful index 
in excluding, wi th a relatively high degreeof certainty, a 
concomitant restrictive disorder in this subset of patients, 
based on spriometric analysis alone. As expected, as the 
FEVi/FVC% decreased, there was a greater tendency 
toward hyperinflation as manifested by increasing lung 
volumes (R = .65). In fact, as shown by parametric dis-
criminant analysis, when the FEVi/FVC% was less than or 
equal to 8 1 % of predicted, only 7% of patients had a total 
lung capacity of less than 80%. Of the 17 cases with 
restrictive lung disease in addition to air f low obstruc-
t ion and a low FEVi/FVC%, clinical and roentgeno-
graphic evaluation disclosed a definite cause for restric-
tive disease in the 12 (100%) patients for whom we had 
adequate clinical and roentgenographic data. 
Thus, the FEVi/FVC% as compared to its predicted value 
provides a useful, accurate means of detecting restric-
tive disease from spirometry alone. It is particularly valu-
able in the presence of airflow obstruction when the 
FVC may be markedly reduced. Thus, when airflow 
obstruction is most severe, concomitant restrictive dis-
ease is highly unlikely, even in the presence of a reduced 
FVC, unless strong clinical and/or roentgenographic 
evidence indicates its presence. This f inding counters 
the common clinical spirometric interpretation, which 
may often suggest mixed restrictive and obstructive dis-
ease. When airflow obstruction is less severe, spirometry 
provides little discrimination. The use of the FEVi/FVC% 
provides the clinician wi th a reasonable means of pre-
dicting static lung volume determinations without requir-
ing their actual performance. The reassurance provided 
by this measurement together with the associated sav-
ings in cost should reinforce the utility of this ratio as a 
routine spirometric calculation. 
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Invasive O f i f i s E x t e r n a 
In 1959, an elderly diabetic man died from a pseudomo-
nas osteomylitis of the mandible and zygoma. Ten years 
later 13 patients were reported who had an external 
otitis fol lowing pseudomonas infections which spread to 
the adjacent soft tissues and bony structures o f the skull. 
Becauseof the severity of the infection and its indolently 
invasive course, the term "malignant otitis externa" was 
coined. Recently an extensive review added another 21 
cases, and the term, invasive external otitis, was sug-
gested. (Doroghazi RM, Nadol JB, Hyslop NE, Baker AS, 
Axelrod L. Invasive external otitis: Report of 21 cases and 
review of the literature. Am J Med 1981;71:603-14). 
Unilateral aural pain, ear canal drainage, local granula-
t ion tissue, and occasionally a perforated tympanic 
membrane occur. A persistent infection may extend to 
the soft tissues and bony structures adjacent to the ear 
canal. Cranial nerve palsies, especially the facial, are 
present in one of three patients. The facial nerve palsy is 
usually permanent. Ninety percent of the patients with 
invasive external otitis are elderly diabetics, and men 
predominately. Pseudomonas aeruginosa is uniformly 
cultured. Although the pathogenesis is poorly under-
stood, local diabetic microangiopathy and poor local 
tissue perfusion seem to favor the spread of the pseu-
domonas infection. 
Recognition and early diagnosis are mandatory. Success-
ful therapy includes a three-to-six-week parenteral course 
of an aminoglycoside (tobramycin or gentamicin) and a 
semisynthetic penicillin (ticarcillin or carbencillin). Sur-
gical treatment is required when soft and bony tissue 
involvement is extensive. Mortality may be 15%. 
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